Director · Pharma-Bio Serv, Inc. · Pharma-Bio Serv, Inc. — Stock Option
Side
A
Value
—
Shares
20.0K
Price
—
Executed
Jan 10, 2026
Disclosed
Jan 14, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Jan 10 executedJan 14, 2026 disclosed
PBSV · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+6 / 15
Disclosed 3 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Wiesen Irving L filed this Form 4 reporting a grant or award of PBSV on Jan 10, 2026. It became public on Jan 14, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Wiesen Irving Lcik:0001351097
Issuer
Pharma-Bio Serv, Inc.cik:0001304161
Revision history · 0
No field has changed since this record was first ingested.
